Many CLL Patients Are Not Receiving Recommended First-Line Treatment
Many patients with CLL are not receiving recommended first-line treatment with BTK inhibitors or BCL2 inhibitors, data suggest. Many patients with CLL are not receiving recommended first-line treatment with BTK inhibitors or BCL2 inhibitors, data suggest.
Source: cancertherapyadvisor.com
